• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯噻嗪用于治疗肾性、肝性和心性水肿。

Xipamide in the management of renal, hepatic and cardiac oedema.

作者信息

Gold C H, Viljoen M

出版信息

S Afr Med J. 1978 Sep 30;54(14):569-71.

PMID:366781
Abstract

Xipamide (4-chloro-5-sulphamyl-salicylic acid 2', 6'-dimethylanilide) is a diuretic and antihypertensive agent. A clinical trial of the drug was performed in 11 patients, 8 with nephrotic syndrome, 1 with oedema and ascites due to hepatic cirrhosis, and 2 with congestive cardiac failure due to idiopathic cardiomyopathy. The drug proved to be potent, safe and efficacious. Side-effects were similar to those encountered with other thiazide-derived diuretics, but were not of a severe nature. Wider clinical usage of xipamide would appear to be warranted.

摘要

氯磺水杨胺(4-氯-5-氨磺酰基水杨酸2',6'-二甲基苯胺)是一种利尿剂和抗高血压药。对11例患者进行了该药物的临床试验,其中8例患有肾病综合征,1例因肝硬化导致水肿和腹水,2例因特发性心肌病导致充血性心力衰竭。该药物被证明有效、安全且高效。副作用与其他噻嗪类利尿剂相似,但并不严重。氯磺水杨胺似乎有必要进行更广泛的临床应用。

相似文献

1
Xipamide in the management of renal, hepatic and cardiac oedema.氯噻嗪用于治疗肾性、肝性和心性水肿。
S Afr Med J. 1978 Sep 30;54(14):569-71.
2
[My prescription of diuretics].[我的利尿剂处方]
Nihon Rinsho. 1974 Aug;32(8):2675-80.
3
Clinical trial of a new diuretic, bumetanide, in seriously ill patients.新型利尿剂布美他尼用于重症患者的临床试验。
Ann Clin Res. 1974 Oct;6(5):272-8.
4
A patient compliance comparative study of three diuretics in the treatment of oedema.
J Int Med Res. 1980;8(5):351-3. doi: 10.1177/030006058000800509.
5
[Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].[氯磺丙脲的作用机制及其作为“低效能利尿剂”的分类。在健康志愿者以及肾脏和肝脏疾病患者中的药效学-药代动力学研究]
Arzneimittelforschung. 2005;55(1):1-14. doi: 10.1055/s-0031-1296819.
6
Polythiazide as a diuretic. A clinical trial.多噻嗪作为一种利尿剂:一项临床试验
J Indian Med Assoc. 1967 Jan 1;48(1):13-7.
7
[Diuretic treatment].[利尿治疗]
Schweiz Med Wochenschr. 1969 Feb;99(7):223-8.
8
Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.肝硬化腹水:利尿剂抵抗的发病机制及托拉塞米的长期疗效与安全性
Cardiology. 1994;84 Suppl 2:87-98. doi: 10.1159/000176461.
9
Thiazide therapy: experience with parenteral administration.
Curr Ther Res Clin Exp. 1965 Oct;7(10):617-24.
10
[The treatment of hydropigenous syndromes with ethacrynic acid. (Apropos of 100 cases)].用依他尼酸治疗水潴留综合征(附100例报告)
Sem Hop. 1967 Jan 8;43(2):95-106.

引用本文的文献

1
Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.氯噻嗪在肾功能正常和受损患者中的药效学和药代动力学。
Eur J Clin Pharmacol. 1984;26(4):513-20. doi: 10.1007/BF00542150.
2
Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.氯噻嗪。对其药效学、药代动力学特性及治疗效果的综述。
Drugs. 1985 Oct;30(4):313-32. doi: 10.2165/00003495-198530040-00002.